Hypermethylation of CCDC181, GCM2 and ITPRIPL1 was found in more than 80% of patients with lower tumor histologic grades, and in 70% of early-stage breast cancer among all subtypes of breast cancer patients (Table 1). This evidence concerns the gene GCM2 and breast carcinoma.